Medicare Enrolled

Dr. Roman Zuckerman, D.O.

Student in an Organized Health Care Education/Training Program · Neptune, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1945 STATE ROUTE 33, Neptune, NJ 07753
7327764483
In practice since 2015 (11 years)
NPI: 1639563927 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zuckerman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zuckerman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zuckerman

Dr. Roman Zuckerman is a student in an organized health care education/training program specialist in Neptune, NJ, with 11 years of NPI registration. Based on federal Medicare data, Dr. Zuckerman performed 24,029 Medicare services across 1,021 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zuckerman received a total of $3,883 from 23 pharmaceutical and/or device companies across 259 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zuckerman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 1% volume in NJ $3,883 industry payments

Medicare Practice Summary

Medicare Utilization ↗
24,029
Medicare services
Top 1% in NJ for student in an organized health care education/training program
1,021
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,184 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
11,925 $10 $60
Denosumab injection (Prolia/Xgeva) 6,480 $18 $36
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
3,670 $26 $100
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
663 $104 $279
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
393 $8 $15
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
169 $60 $274
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
140 $107 $541
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
129 $12 $72
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
129 $1 $29
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
118 $132 $594
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
113 $25 $115
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
36 $160 $394
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $78 $181
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
24 $116 $312
New patient office visit, complex (60-74 min) 15 $184 $745
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
66.7% high complexity
28.1% medium
5.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,883
Total received (2018-2024)
Avg $555/year across 7 years
Top 9% in NJ for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
259
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,709 (95.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$174 (4.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,009
2023
$366
2022
$1,178
2021
$717
2020
$161
2019
$409
2018
$42

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$241
Amgen Inc.
$228
ABBVIE INC.
$207
Novartis Pharmaceuticals Corporation
$110
Lilly USA, LLC
$89
E.R. Squibb & Sons, L.L.C.
$66
PFIZER INC.
$18
Genentech USA, Inc.
$17
Johnson & Johnson Health Care Systems Inc.
$17
UCB, Inc.
$17
Top 3 companies account for 67.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$981
ABBVIE INC.
$443
E.R. Squibb & Sons, L.L.C.
$406
GlaxoSmithKline, LLC.
$300
PFIZER INC.
$269
Janssen Biotech, Inc.
$241
Horizon Therapeutics plc
$170
Lilly USA, LLC
$168
UCB, Inc.
$141
AbbVie Inc.
$135
Aurinia Pharma U.S., Inc.
$121
Novartis Pharmaceuticals Corporation
$110
SANOFI-AVENTIS U.S. LLC
$100
Genentech USA, Inc.
$91
AstraZeneca Pharmaceuticals LP
$58
Azurity Pharmaceuticals, Inc.
$29
Hikma Pharmaceuticals USA
$28
Organon LLC
$17
Johnson & Johnson Health Care Systems Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$15
Sobi, Inc
$15
SOBI, INC
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 47.1% of all-time payments
Associated products mentioned in payments ›
Actemra · BENLYSTA · BOTOX · Bimzelx · CHANTIX · COSENTYX · Cimzia · ELIQUIS · ENTYVIO · EVENITY · Enbrel · HADLIMA · HUMIRA · Horizant · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · Mitigare · ORENCIA · PRADAXA · RINVOQ · Rituxan · SKYRIZI · TALTZ · TAVNEOS · TREMFYA · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for student in an organized health care education/training program in NJ.

Looking for a student in an organized health care education/training program specialist in Neptune?
Compare student in an organized health care education/training programs in the Neptune area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs within 10 mi
1,174
Per 100K population
182.4
County median income
$122,727
Nearest hospital
MONMOUTH MEDICAL CENTER
7.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Zuckerman is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with low-engagement industry engagement in the top 9% of NJ peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Zuckerman experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Zuckerman performed 11,925 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zuckerman receive payments from pharmaceutical companies?
Yes. Dr. Zuckerman received a total of $3,883 from 23 companies across 259 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zuckerman's costs compare to other student in an organized health care education/training programs in Neptune?
Dr. Zuckerman's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zuckerman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →